SCHEMBL29486367

SCHEMBL29486367

O=S(=O)(O)C(O)c1ccccn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
NPSR1 Q6W5P4 1/20 0.47
SLC6A3 Q01959 2/20 0.45
SLC6A2 P23975 1/20 0.45
SLC6A4 P31645 1/20 0.45
TP53 P04637 1/20 0.42
RECQL P46063 1/20 0.42
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
MEN1 O00255 1/20 0.41
GAA P10253 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ALDH1A1 P00352 1/20 0.41
KCNA5 P22460 3/20 0.40
TSHR P16473 2/20 0.40
MAPT P10636 1/20 0.40
KCNE1 P15382 1/20 0.40
SLC10A1 Q14973 1/20 0.40
NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1374510 1.00 KDM4E (0.49) KDM4ENPSR1SLC6A3SLC6A2SLC6A4
SCHEMBL2375133 0.84 KDM4E (0.50) KDM4ENPSR1SLC6A3SLC6A2SLC6A4
SCHEMBL4807002 0.80 CYP1A2 (0.47) KDM4ENPSR1SLC6A3SLC6A2SLC6A4
SCHEMBL28001481 0.80 SLC6A3 (0.42) KDM4ENPSR1SLC6A3SLC6A2SLC6A4
SCHEMBL14571412 0.80 KDM4E (0.42) KDM4ENPSR1SLC6A3SLC6A2SLC6A4
SCHEMBL27652094 0.79 CYP1A2 (0.46) KDM4ENPSR1SLC6A3SLC6A2SLC6A4
SCHEMBL11551880 0.79 CYP1A2 (0.46) KDM4ENPSR1SLC6A3SLC6A2SLC6A4
SCHEMBL27652093 0.79 CYP1A2 (0.46) KDM4ENPSR1SLC6A3SLC6A2SLC6A4
SCHEMBL27996727 0.77 SLC6A2 (0.53) KDM4ENPSR1SLC6A3SLC6A2SLC6A4
SCHEMBL28225638 0.77 KDM4E (0.44) KDM4ENPSR1SLC6A3SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4687916-A1 OLIGOSACCHARIDE PREPARATION COUNTERACTING RESPIRATORY DISEASE EFFECT DSM IP Assets B.V. (NL) 2026-02-11 EP disclosed
EP-4561588-A1 REDUCING NECROTIC ENTERITIS EFFECT IN A BIRD USING AN OLIGOSACCHARIDE PREPARATION DSM IP Assets B.V. (NL) 2025-06-04 EP disclosed
EP-4489584-A1 IMPROVING LAYER BIRD PERFORMANCE USING AN OLIGOSACCHARIDE PREPARATION DSM IP Assets B.V. (NL) 2025-01-15 EP disclosed
EP-4482323-A1 MEANS AND METHODS FOR MODULATING SECONDARY METABOLITE IN AN ANIMAL DSM IP Assets B.V. (NL) 2025-01-01 EP disclosed
EP-4447703-A1 USE OF OLIGOSACCHARIDE PREPARATION TO INCREASE PERFORMANCE OF ANIMAL VACCINATED AGAINST COCCIDIOSIS DSM IP Assets B.V. (NL) 2024-10-23 EP disclosed
WO-2024208938-A1 OLIGOSACCHARIDE PREPARATION COUNTERACTING RESPIRATORY DISEASE EFFECT DSM IP ASSETS B.V. (NL) 2024-10-10 WO disclosed
WO-2024023198-A1 REDUCING NECROTIC ENTERITIS EFFECT IN A BIRD USING AN OLIGOSACCHARIDE PREPARATION DSM IP ASSETS B.V. (NL) 2024-02-01 WO disclosed
WO-2023170049-A1 IMPROVING LAYER BIRD PERFORMANCE USING AN OLIGOSACCHARIDE PREPARATION DSM IP ASSETS B.V. (NL) 2023-09-14 WO disclosed
WO-2023161312-A1 MEANS AND METHODS FOR MODULATING SECONDARY METABOLITE IN AN ANIMAL DSM IP ASSETS B.V. (NL) 2023-08-31 WO disclosed
WO-2023110658-A1 USE OF OLIGOSACCHARIDE PREPARATION TO INCREASE PERFORMANCE OF ANIMAL VACCINATED AGAINST COCCIDIOSIS DSM IP ASSETS B.V. (NL) 2023-06-22 WO disclosed
EP-4118090-A1 METHODS OF MODULATING GASTROINTESTINAL MICROBIAL METABOLIC PATHWAYS AND METABOLITES DSM IP Assets B.V. (NL) 2023-01-18 EP disclosed
EP-4051726-A1 CURABLE COMPOSITIONS OF BENZOXAZINE AND PHTHALONITRILE RESINS Huntsman Advanced Materials Americas LLC (US) 2022-09-07 EP disclosed
EP-4051727-A1 PHTHALONITRILE RESINS, METHODS OF MAKING SAME AND COMPOSITIONS THEREOF Huntsman Advanced Materials Americas LLC (US) 2022-09-07 EP disclosed